Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Recurrence 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Leukemia 1 Disease 1 Central Nervous System Neoplasms 1

Interventions

pembrolizumab 24 Carboplatin 21 Paclitaxel 20 olaparib 19 Magnetic Resonance Spectroscopy 14 Bevacizumab 14 Cyclophosphamide 12 Specimen Handling 11 Nivolumab 11 Gemcitabine 11 Taxes 10 niraparib 8 Cisplatin 8 Biopsy 8 liposomal doxorubicin 7 fludarabine 7 Surveys and Questionnaires 6 Immunoglobulin G 6 Doxorubicin 6 Disulfides 6 durvalumab 5 palbociclib 4 oregovomab 4 X-Rays 4 Ipilimumab 4 mirvetuximab soravtansine 3 ipatasertib 3 defactinib 3 cediranib 3 atezolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ovarian Neoplasms × neratinib × Clear all

NCT04502602 2026-05-11

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡